Evidence map›Paper›PMID 41635306›Full record

ArticleBiosafety and health2025

Genomic characteristics of 12 HBV-I strains in the 2020 national HBV serosurvey in China.

Qiudong Su, Liping Shen, Xiaoqi Guo, Shuang Zhang, Feng Qiu, Shengli Bi, Feng Wang

Abstract read
In one paragraph

Article in Biosafety and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qiudong SuNHC Key Laboratory of Medical Virology and Viral Diseases, National Institute For Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing 102206, China.
Liping ShenNHC Key Laboratory of Medical Virology and Viral Diseases, National Institute For Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing 102206, China.
Xiaoqi GuoNHC Key Laboratory of Medical Virology and Viral Diseases, National Institute For Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing 102206, China.
Shuang ZhangNHC Key Laboratory of Medical Virology and Viral Diseases, National Institute For Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing 102206, China.
Feng QiuNHC Key Laboratory of Medical Virology and Viral Diseases, National Institute For Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing 102206, China.
Shengli BiNHC Key Laboratory of Medical Virology and Viral Diseases, National Institute For Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing 102206, China.
Feng WangNHC Key Laboratory of Medical Virology and Viral Diseases, National Institute For Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing 102206, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B virus (HBV) is categorized into ten distinct genotypes (A - J), with over 40 subgenotypes identified to date. HBV genotype I (HBV-I), an inter-genotypic recombinant, has emerged during the evolution history of HBV. In this study, we conducted a comprehensive analysis of the genomic characteristics of HBV-I in China, employing a range of methodologies including phylogenetic analysis, nucleotide homology assessment, examination of amino acid substitutions within the PreS/S region, recombination detection, and evolutionary analysis. The 12 HBV-I strains, classified into subgenotype I1 and predominantly serotype

Indexed as

Evolutionary analysisGenotype IHepatitis B virus (HBV)Homology analysisPreS/S mutations

Identifiers

PMID41635306
PMCPMC12861751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.